The medical device and diagnostics market is set to grow at 4.5 percent per year (CAGR) between 2012 and 2018, totalling $455 billion in 2018, according to the newly-released EvaluateMedTech World Preview 2013, Outlook to 2018: The Future of Medtech report from market intelligence firm Evaluate Ltd.
The WaveCrest LAA Occluder is an implantable device that seals off the LAA opening so clots cannot escape into the blood stream and cause a stroke. It is a one-time treatment option for patients who would otherwise be on a lifetime regimen of anticoagulation therapy.
Florida Hospital Collaborates with VTT of Finland to Explore Research for Early Detection of Alzheimer’s DiseaseSeptember 19, 2013 11:36 am | by Technical Research Centre of Finland (VTT) | News | Comments
In an effort to better understand the development of Alzheimer’s disease, Florida Hospital Neuroscience Institute and VTT Technical Research Centre of Finland are collaborating to identify the biomarker assay that may predict early onsets of the disease.
The researchers have developed a method that improves the delimitation of tumors in medical images. As they explained, “when the doctor decides where tumor tissue should be separated from healthy tissue, our algorithm ensures that he/she is never going choose the worst option because the best solution is automatically offered.”
The CE marked TriGuard is the only device designed to cover all three aortic cerebral branches to minimize the risk of cerebral damage during Transcatheter Aortic Valve Replacement (TAVR) and other cardiovascular procedures. It is the only system designed for placement via one of two femoral artery access ports.
A voice-analysis program run on a tablet could help high school and youth coaches recognize concussions on the sidelines of football and other high-impact sport games. After identifying concussions in collegiate boxers in a preliminary study, University of Notre Dame researchers will soon test the app on approximately 1,000 youth and high school football players.
Surgery is the cornerstone of oncology treatment, and molecularly-targeted fluorescent imaging agents have the potential to guide surgical resection by highlighting the biological margins of the disease. However, development and testing of such molecular imaging agents has been lacking.
The structure of the brain may predict whether a person will suffer chronic low back pain, according to researchers who used brain scans. The results, published in the journal Pain, support the growing idea that the brain plays a critical role in chronic pain, a concept that may lead to changes in the way doctors treat patients.
Neuros Medical, Inc., a medical device company announced it has received an Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration for their implantable generator. The device, named Altius™, delivers patented high frequency Electrical Nerve Block™ technology for patients suffering from chronic pain.
Spinal injuries are present in 1 out of 9 U.S. military personnel sustaining combat injuries in Iraq or Afghanistan -- a much higher rate than in previous wars, according to a report in the Sept. 15 issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Just as wires must be insulated to effectively carry electrical impulses, nerve cells must be insulated by myelin to effectively transmit neural impulses. Using typical magnetic resonance imaging or MRI, one can visually distinguish parts of the brain that look white and parts that look gray.
A new EU project, METSY, develops and applies neuroimaging and bioinformatics tools to study how lipid metabolism is connected to psychotic disorders and metabolic co-morbidities such as metabolic syndrome and diabetes. The overall objective is to identify, prioritize and evaluate multi-modal blood and neuroimaging biomarkers...
If the violins were taken away from the musicians performing Beethoven's 9th symphony, the resulting composition would sound very different. If the violins were left on stage but the violinists were removed, the same mutant version of the symphony would be heard. But what if it ended up sounding like "Hey Jude" instead?
On this episode of The Pulse, brought to you by MDT TV, we’re removing brain tumors with robots, using MetaboShield to help obesity, regenerating heart tissue, and pairing glucometers with smartphones for ease of use.
The largest study of computed tomographic (CT) scans taken in emergency departments across the country for children with head injuries describes the prevalence of “incidental findings” and categorizes them by urgency. The study involved nearly 44,000 children seen for a head injury in 25 hospital emergency departments nationwide. Nearly 16,000 had CT scans to evaluate an injury, and about 4 percent of the scans revealed...
The researchers found that ND–DOX levels in the tumors were retained for a duration far beyond that of doxorubicin alone, showing that doxorubicin was taken into the tumor and remained their longer when attached to nanodiamonds. In addition, ND–DOX was also found to increase...
Arch Biopartners Inc announced today that the U.S. Patent and Trademark Office has issued US Patent 8,530,429 protecting its peptide technology which targets brain tumour initiating cells (BTICs) and invasive glioma cells (IGCs). The patent protects novel synthetic peptides that target and attach to human BTICs and IGCs.
Award-winning medical design and development company Team Consulting has today unveiled an innovative concept that has the potential to address two significant unmet clinical needs; early detection of cancer regrowth following surgery and detection of infection within chronic wounds.
By studying how memories are made, UC Irvine neurobiologists created new, specific memories by direct manipulation of the brain, which could prove key to understanding and potentially resolving learning and memory disorders. Research led by senior author Norman M. Weinberger and colleagues has shown that specific memories can be made by directly altering brain cells in the cerebral cortex...
The end-of-August announcement that the National Football League will pay $765 million to settle a lawsuit involving thousands of its former players over problems related to head trauma is just one sign of the growing concern that the sport’s collisions pose a serious risk to long-term player health.
The birth of artificial-intelligence research as an autonomous discipline is generally thought to have been the monthlong Dartmouth Summer Research Project on Artificial Intelligence in 1956, which convened 10 leading electrical engineers — including MIT’s Marvin Minsky and Claude Shannon — to discuss “how to make machines use language” and “form abstractions and concepts.”
European Launch of New Version of Codman Neuro’s Revive SE Thrombectomy Device for Treatment of Acute Ischemic StrokeSeptember 9, 2013 2:06 pm | by Codman Neuro | News | Comments
Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, announced the European launch of the REVIVE™ SE Thrombectomy Device, a next generation clot removal device offering enhanced navigation through the cerebral vasculature and rapid restoration of blood flow to the brain after an ischemic stroke.
Two scientists who illuminated how brain cells communicate, three researchers who developed implants that let deaf people hear and philanthropists Bill and Melinda Gates have won prestigious Lasker Awards for medical research and contributions to public health.
Researchers in Vienna develop new imaging technique to study the function of entire nervous systems Scientists at the Campus Vienna Biocenter have found a way to overcome some of the limitations of light microscopy. Applying the new technique, they can record the activity of a worm’s brain with high temporal and spatial resolution, ultimately linking brain anatomy to brain function.
Keystone Heart, a leader in the development of cerebral protection devices for interventional cardiology and cardiac surgery procedures, announced today that its TriGuardT Cerebral Protection Device has received CE Marking, enabling the company to commercially market the TriGuard in Europe and other territories.